FG-4592 100mg 100mg | Purity Not Available
Adooq Bioscience
FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.
More Information Supplier PageSearch Results
FG-4592 10mg 10mg | Purity Not Available
Adooq Bioscience
FG-4592 is a novel hypoxia inducible factor prolyl hydroxylase inhibitor, in CKD anemia.
More Information Supplier PageTAK-285 50mg 50mg | Purity Not Available
Adooq Bioscience
TAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).
More Information Supplier PageTAK-438 2mg 2mg | Purity Not Available
Adooq Bioscience
TAK-438 25mg 25mg | Purity Not Available
Adooq Bioscience
BMS-911543 50mg 50mg | Purity Not Available
Adooq Bioscience
BMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity.
More Information Supplier PageBMS-911543 5mg 5mg | Purity Not Available
Adooq Bioscience
BMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity.
More Information Supplier PageBMS-911543 25mg 25mg | Purity Not Available
Adooq Bioscience
BMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity.
More Information Supplier PageBMS-911543 10mg 10mg | Purity Not Available
Adooq Bioscience
BMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity.
More Information Supplier PageMLN2480 (BIIB-024) 50mg 50mg | Purity Not Available
Adooq Bioscience
MLN 2480 is an oral, selective pan-Raf kinase inhibitor in chinical trials.
More Information Supplier Page